SB 3442, the Metastatic Breast Cancer Access to Care Act, would amend the Social Security Act to remove federal waiting periods for two benefits for individuals with metastatic breast cancer. First, it would allow eligible individuals to receive Social Security disability insurance benefits without the usual waiting period currently applied under section 223(a). Second, it would waive the 24-month Medicare waiting period for those individuals, aligning their access to Medicare coverage more quickly after disability eligibility.
The bill is narrowly targeted and applies only to people with metastatic breast cancer. Its disability insurance changes would apply to applications filed after enactment, while the Medicare change would apply to benefits for months beginning after enactment. In practical terms, the bill would create a new statutory exception similar to the existing expedited treatment for amyotrophic lateral sclerosis (ALS), which is the condition currently referenced in the Social Security Act provisions being amended.
Impact
If enacted, the bill would directly amend title II of the Social Security Act by adding metastatic breast cancer to the list of conditions exempt from the standard waiting periods for disability insurance benefits and Medicare coverage. It would affect federal benefit administration rather than state law, but it would have significant consequences for affected beneficiaries by accelerating access to income support and health coverage. The bill would also require the Social Security Administration and Medicare to process qualifying metastatic breast cancer cases under the new exception.
Sentiment
The available record shows a generally supportive posture around the bill, with bipartisan sponsorship from Senators Murphy and Murkowski and no recorded committee opposition, amendments, or votes in the provided materials. The bill’s title and structure suggest a focused access-to-care measure intended to address a serious disease-specific hardship. Because there are no transcripts or vote tallies, the broader sentiment can only be inferred from the bill’s introduction and referral: it appears to be a targeted, compassionate health-access proposal with limited visible controversy in the available record.
Contention
No specific points of contention are documented in the provided materials. Potential areas of debate, based on the bill text, could include whether metastatic breast cancer should receive the same waiting-period exemption already afforded to ALS, and whether creating a disease-specific exception is preferable to broader reform of disability and Medicare waiting periods. However, no committee discussion, recorded objections, or vote-based divisions are available here to identify actual opposing arguments or stakeholders.